Indication
Partial
8 clinical trials
13 products
1 drug
Clinical trial
A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Ucb L059) In Children With EpilepsyStatus: Completed, Estimated PCD: 2006-01-25
Product
LevetiracetamClinical trial
An Open-label, Exploratory, Multicenter, Dose-escalation Study Examining the Efficacy, Safety and Tolerability of Ucb 44212 Used at Doses of 10 mg, 20 mg, 40 mg and 80 mg b.i.d. (Total Daily Dose of 20 to 160 mg) in Adult Subjects (18-65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures (Whether or Not Secondarily Generalized) and Treated With 1, 2 or 3 Approved Antiepileptic DrugsStatus: Completed, Estimated PCD: 2006-05-03
Product
SeletracetamClinical trial
An Open Label, Exploratory, Dose-escalation, Multicenter Study Examining the Safety, Tolerability and Efficacy of Ucb 44212 (Seletracetam) Used at Doses of 10, 20, 40, and 80 mg b.i.d. (Total Daily Doses of 20 - 160 mg) Administration (Oral Capsules) in Adult Subjects (18 - 65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures Who Are Currently Receiving Levetiracetam (LEV) But Still Experiencing SeizuresStatus: Completed, Estimated PCD: 2006-05-12
Clinical trial
An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.Status: Completed, Estimated PCD: 2009-12-01
Product
ganaxoloneClinical trial
Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal EpilepsyStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Product
ZonisamideClinical trial
Efficacy and Tolerability of Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy (STANDLOW). A Multicenter, Randomized, Single-blind, Parallel-group TrialStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
CarbamazepineProduct
ValproateProduct
OxcarbazepineProduct
TopiramateProduct
LamotrigineProduct
GabapentinClinical trial
Exploratory Open-Label Study of Effects on Responsive Neurostimulator Activity After Intranasal Administration of Single Dose of Valtoco® to People With EpilepsyStatus: Completed, Estimated PCD: 2022-11-10
Product
Nasal DiazepamClinical trial
An Initial Clinical Study to Treat Postictal SymptomsStatus: Recruiting, Estimated PCD: 2025-01-01
Product
IbuprofenProduct
NifedipineDrug
Varlilumab